French study checks if new combo works for mesothelioma in everyday practice
NCT ID NCT05308966
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks back at 204 patients with untreated, inoperable malignant pleural mesothelioma who received a combination of two immunotherapy drugs, nivolumab and ipilimumab, through an early access program in France. Researchers will collect data from medical records to see how long patients lived without the cancer getting worse and track side effects. The goal is to confirm the benefits seen in an earlier clinical trial and support making this treatment more widely available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
nivolumab and ipilimumab
What this could lead to
If successful, this study could confirm that the nivolumab-ipilimumab combination works well in real-world patients, supporting its wider use and reimbursement for mesothelioma.
What could go wrong
This is a retrospective observational study, not a controlled trial, so results may be less reliable. It only looks at patients already treated, and outcomes may vary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT PLEURAL MESOTHELIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CAC Mougins
Mougins, 06250, France
-
CH Albi
Albi, 81013, France
-
CH Annecy Genevois
Pringy, 74374, France
-
CH Argenteuil
Argenteuil, 95010, France
-
CH Avignon
Avignon, 84000, France
-
CH Bastia
Bastia, 20200, France
-
CH Bayonne
Bayonne, 64100, France
-
CH Bligny
Bligny, 91640, France
-
CH Cannes
Cannes, 06400, France
-
CH Cornouaille
Quimper, 02900, France
-
CH Dijon Bourgogne
Dijon, 21000, France
-
CH Eure-Seine
Évreux, 27015, France
-
CH Libourne
Libourne, 33500, France
-
CH Nevers
Nevers, 58000, France
-
CH St Quentin
Saint-Quentin, 02321, France
-
CH Villefranche
Villefranche-sur-Saône, 69400, France
-
CH Villeurbanne
Villeurbanne, 69100, France
-
CH de Longjumeau
Longjumeau, 91160, France
-
CH de Saint Malo
St-Malo, 35400, France
-
CH du Cotentin
Cherbourg, 50102, France
-
CH du Mans
Le Mans, 72000, France
-
CHD les Oudaries
La Roche-sur-Yon, 85000, France
-
CHITS Toulon Sainte Musse
Toulon, 83056, France
-
CHRU Bretonneau
Tours, 37044, France
-
CHU Angers
Angers, 49033, France
-
CHU Besançon
Besançon, 25000, France
-
CHU Caen
Caen, 14033, France
-
CHU Hôpital Montpied
Clermont-Ferrand, 63000, France
-
CHU La Mileterie
Poitiers, 86021, France
-
CHU Lille
Lille, 59000, France
-
CHU Morvan
Brest, 29200, France
-
CHU Ponchailloux
Rennes, 35000, France
-
CHU du Pays d'Aix
Aix-en-Provence, 13616, France
-
Centre Antoine Lacassagne
Nice, 06149, France
-
Centre Léon Bérard
Lyon, 69373, France
-
Clinique Ambroise Paré
Beuvry, 63660, France
-
Clinique Bordeaux
Bordeaux, 33000, France
-
Clinique Gentilly
Gentilly, 94250, France
-
Clinique Pasteur
Brest, 29200, France
-
Clinique Saint Georges
Nice, 06000, France
-
Clinique Saint Grégoire
Rennes, 35000, France
-
Clinique de l'Estuaire
Saint-Nazaire, 44600, France
-
GH Le Havre
Le Havre, 76083, France
-
GH Paris Site St Joseph
Paris, 75674, France
-
HIA Begin
Saint-Mandé, 94160, France
-
HIA St Anne
Toulon, 83800, France
-
Hôpital Ambroise Paré
Boulogne-Billancourt, 92100, France
-
Hôpital Bichat
Paris, 75018, France
-
Hôpital Charles Nicolle
Rouen, 76031, France
-
Hôpital Cochin
Paris, 75014, France
-
Hôpital Haut-Lévèque - Groupe Hospitalier SUD
Pessac, 33604, France
-
Hôpital La Pitié-Salpêtrière
Paris, 75651, France
-
Hôpital Larrey
Toulouse, 31059, France
-
Hôpital Louis Pasteur
Colmar, 68000, France
-
Hôpital Louis Pradel
Bron, 69500, France
-
Hôpital Nord
Marseille, 13915, France
-
Hôpital du Scorff
Lorient, 56100, France
-
Hôpital privé de la Loire
Saint-Etienne, 42100, France
-
IPC
Marseille, 13009, France
-
Insititut de Cancerologie de l'Ouest
Saint-Herblain, 44805, France
-
Institut Curie
Paris, 75005, France
-
Les Hôpitaux Universitaires de Strasbourg
Strasbourg, 76091, France
-
Unicancer
Clermont-Ferrand, 63000, France